Literature DB >> 8839122

The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes.

D Papakostopoulos1, J C Hart, R J Corrall, B Harney.   

Abstract

Pattern reversal visual evoked responses (PR-VEPs), the electroretinogram (ERG) to blue flashes of light in dark adaptation, the steady state ERG to 40 Hz flicker, and alterations in pupil diameter following dark adaptation were studied in 56 juvenile onset diabetics, 34 of whom had no ophthalmoscopic or photographic evidence of diabetic retinopathy (DR-group). The remaining 22 had mild background retinopathy (DR+group). Normal data was obtained from 24 subjects matched for age and sex with diabetics. Skin electrodes were used for all recordings. The scotopic 'b' wave of the ERG was significantly lower in amplitude in the DR- diabetics and it was even more reduced in the DR+group. The PR-VEP was significantly delayed in diabetics but there was no difference between the two groups. The steady state ERG was not significantly different between normals and diabetics. These findings indicate that retinal and more central abnormalities develop early in diabetics. Detection of objective electrophysiological abnormalities may be used to identify persons at risk of developing retinopathy and to monitor the effects of treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8839122     DOI: 10.1016/0167-8760(95)00040-2

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  9 in total

1.  Protective Effects of Adeno-associated Virus Mediated Brain-derived Neurotrophic Factor Expression on Retinal Ganglion Cells in Diabetic Rats.

Authors:  Yan Gong; Zhan-Ping Chang; Ruo-Tong Ren; Shi-Hui Wei; Huan-Fen Zhou; Xiao-Fei Chen; Bao-Ke Hou; Xin Jin; Mao-Nian Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-02       Impact factor: 5.046

2.  The effect of post prandial glucose changes on oscillatory potentials in subjects with type 2 diabetes mellitus.

Authors:  Dominique V Arlotte; Rhianon L Perrott; Neville Drasdo; David R Owens; Rachel V North
Journal:  Doc Ophthalmol       Date:  2004-07       Impact factor: 2.379

3.  Multifocal electroretinogram in diabetic subjects.

Authors:  Mona Abdelkader
Journal:  Saudi J Ophthalmol       Date:  2012-03-17

Review 4.  Role of Electrophysiology in the Early Diagnosis and Follow-Up of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Andrea Barbato; Alessio Stefanucci; Giuseppe Buomprisco
Journal:  J Diabetes Res       Date:  2015-05-05       Impact factor: 4.011

5.  To see or not to see; the ability of the magno- and parvocellular response to manifest itself in the VEP determines its appearance to a pattern reversing and pattern onset stimulus.

Authors:  Valentine L Marcar; Lutz Jäncke
Journal:  Brain Behav       Date:  2016-08-25       Impact factor: 2.708

6.  Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy.

Authors:  Cara T Motz; Kyle C Chesler; Rachael S Allen; Katie L Bales; Lukas M Mees; Andrew J Feola; April Y Maa; Darin E Olson; Peter M Thule; P Michael Iuvone; Andrew M Hendrick; Machelle T Pardue
Journal:  Diabetes       Date:  2020-02-12       Impact factor: 9.461

7.  Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes.

Authors:  Leif E Johnson; Michael Larsen; Maria-Thereza Perez
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

8.  Shades of grey; Assessing the contribution of the magno- and parvocellular systems to neural processing of the retinal input in the human visual system from the influence of neural population size and its discharge activity on the VEP.

Authors:  Valentine L Marcar; Silvana Baselgia; Barbara Lüthi-Eisenegger; Lutz Jäncke
Journal:  Brain Behav       Date:  2018-02-01       Impact factor: 2.708

9.  Role of Arginase 2 in Murine Retinopathy Associated with Western Diet-Induced Obesity.

Authors:  Reem T Atawia; Katharine L Bunch; Abdelrahman Y Fouda; Tahira Lemtalsi; Wael Eldahshan; Zhimin Xu; Alan Saul; Khaled Elmasry; Mohamed Al-Shabrawey; Ruth B Caldwell; R William Caldwell
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.